Literature DB >> 11144677

The 31P-NMR stress test: an approach for detecting myocardial ischemia.

E J Butterworth1, W T Evanochko, G M Pohost.   

Abstract

31P-NMR spectroscopy has the potential to assess myocardial damage directly and noninvasively by ascertaining the relative abundances of phosphorus-containing compounds relevant to metabolism under stress conditions. Decrease in the PCr/ATP ratio during exercise is an indicator of the level of stress to which the myocardium is subject. This ratio will remain constant under mild to moderate exercise conditions in a healthy subject, but may show a precipitous decrease even under mild exercise when regions of the myocardium are ischemic. The studies examined here indicate that cardiac patients with some forms of ischemia showed a PCr/ATP ratio decrease even under light exercise, while no decrease was observed in patients whose heart disease was known to be nonischemic. Hypertension and nonstenotic chest pain in women can, in some cases, produce a decrease in PCr/ATP ratio. Only the hypertensive patients showed a significant difference in the prestress PCr/ATP ratio when compared with controls. These studies suggest that 31P-NMR spectroscopy before and during mild exercise in the bore of the magnet can be a useful indicator of the presence or absence of an ischemic component to myocardial disorder.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11144677     DOI: 10.1114/1.1310214

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  2 in total

1.  Renal bioenergetics during early gram-negative mammalian sepsis and angiotensin II infusion.

Authors:  Clive N May; Ken Ishikawa; Li Wan; John Williams; R Mark Wellard; Gaby S Pell; Graeme D Jackson; Rinaldo Bellomo
Journal:  Intensive Care Med       Date:  2012-05       Impact factor: 17.440

2.  Heart of the World's Top Ultramarathon Runner-Not Necessarily Much Different from Normal.

Authors:  Robert Gajda; Anna Klisiewicz; Vadym Matsibora; Dorota Piotrowska-Kownacka; Elżbieta Katarzyna Biernacka
Journal:  Diagnostics (Basel)       Date:  2020-01-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.